This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masiukiewicz, U. S. Articles by Insogna, K. L. Search for Related Content PubMed PubMed Citation Articles by Masiukiewicz, U. S. Articles by Insogna, K. L.

Evidence that the IL-6/IL-6 Soluble Receptor Cytokine System Plays a Role in the Increased Skeletal Sensitivity to PTH in Estrogen-Deficient Women

Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06520-8020

Address all correspondence and requests for reprints to: Dr. Urszula Masiukiewicz, Yale University School of Medicine, P.O. Box 208020, 333 Cedar Street FMP 109, New Haven, Connecticut 06520-8020. E-mail: .

Abstract

Estrogen-deficient women show increased skeletal sensitivity to the resorbing actions of PTH. The basis for this effect is not known. To examine the influence of estrogen deficiency on PTH-induced proresorptive cytokine production in humans, the response of five young women to a 36-h infusion of (1–34)human PTH (hPTH) was studied. PTH induced significant increases in circulating levels of IL-6 (mean values, T₀T_{36 h}; 2.219.2 pg/ml), IL-6 soluble receptor (IL-6sR; 29.867.2 ng/ml), urine N-telopeptide of type I collagen (NTX) (38.6148 nM bone collagen equivalent/mM creatinine) and serum calcium (2.122.62 mmol/liter). To examine the impact of hormonal status on this response, PTH infusions were next undertaken in seven estrogen-deficient and seven estrogen-treated postmenopausal women. When compared with estrogen-treated women, and correcting for differences in baseline values, estrogen-deficient women demonstrated an exaggerated increase in circulating levels of IL-6 (5.031.7 vs. 3.214.4 pg/ml; P = 0.0001) and IL-6sR (49.2102.1 vs. 37.766.7; P = 0.0001). This was accompanied by greater increases in NTX excretion in the estrogen-deficient women (61.2201.6 vs. 44.8114.8, E^- vs. E⁺, P = 0.0001). Estrogen deficiency was not associated with augmented PTH-induced increases in colony-stimulating factor-1, IL-1ß, IL-11, or TNF-. In a multiple regression model controlling for group, age, years since menopause both IL-6 and IL-6sR were strong predictors of NTX. These data, along with previous animal studies, support the conclusion that the IL-6/IL-6SR cytokine system plays a role in the increased skeletal sensitivity to PTH seen in estrogen-deficient women.

This article has been cited by other articles:

				J. J. Wysolmerski Conversations Between Breast and Bone: Physiological Bone Loss During Lactation as Evolutionary Template for Osteolysis in Breast Cancer and Pathological Bone Loss After Menopause IBMS BoneKEy, August 1, 2007; 4(8): 209 - 225. [Abstract] [Full Text] [PDF]

				E. C. Buxton, W. Yao, and N. E. Lane Changes in Serum Receptor Activator of Nuclear Factor-{kappa}B Ligand, Osteoprotegerin, and Interleukin-6 Levels in Patients with Glucocorticoid-Induced Osteoporosis Treated with Human Parathyroid Hormone (1-34) J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3332 - 3336. [Abstract] [Full Text] [PDF]

				J. N. VanHouten and J. J. Wysolmerski Low Estrogen and High Parathyroid Hormone-Related Peptide Levels Contribute to Accelerated Bone Resorption and Bone Loss in Lactating Mice Endocrinology, December 1, 2003; 144(12): 5521 - 5529. [Abstract] [Full Text] [PDF]

				I. A. Nakchbandi, M. A. Mitnick, R. Lang, C. Gundberg, B. Kinder, and K. Insogna Circulating Levels of Interleukin-6 Soluble Receptor Predict Rates of Bone Loss in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4946 - 4951. [Abstract] [Full Text] [PDF]